Target intelligence / Profile preview

Von Willebrand factor A domain-containing protein 3A (VWA3A)

Target
VWA3A
Molecular classification
Other, von Willebrand factor type A domain-containing protein, extracellular protein, protein coding gene
01

Overview

Von Willebrand factor A domain-containing protein 3A (VWA3A) is a human protein coded by the VWA3A gene, found on chromosome 16. It contains a von Willebrand factor type A (vWA) domain, a structural motif commonly involved in cell adhesion, migration, and formation of multiprotein complexes. VWA3A is identified as a robust, disease- and age-independent marker of ependymal cells in the brain and spinal cord, shown to have a promoter that drives strong, specific transcription in ependyma across species. While associated diseases include intellectual developmental disorder and ataxia-telangiectasia-like disorder 2, VWA3A is not implicated as a drug target and currently has no characterized therapeutic relevance or interacting drugs. It is not considered a validated therapeutic target or receptor. No biomarkers or safety concerns have been established. Its main biological relevance is in cell type identity, specifically for ependymal cells, and its promoter's utility for achieving ependyma-specific gene expression in gene therapy vector design, particularly for neurological applications.

Other names
FLJ46765FLJ40941VWA3A
02

Mechanism of action

not applicable (no known drug targeting this protein)

03

Biological functions

Involved in cell adhesion, migration, and interaction within multiprotein complexes due to its von Willebrand factor type A (vWA) domainPossible roles in cilia-associated biology, particularly ependymal cell functionForms part of ependyma gene signatures and serves as a robust, disease- and age-independent marker for ependymal cells lining brain ventricles and the spinal columnPotential structural/adhesive extracellular functionIts promoter is experimentally valuable for achieving ependyma-specific gene expression in gene therapy vector design for neurological applications
04

Disease associations

Intellectual developmental disorderAtaxia-Telangiectasia-like disorder 2Linked to certain rare neurological disorders (not a direct disease target)

Beyond the preview

Go deeper on Von Willebrand factor A domain-containing protein 3A (VWA3A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Von Willebrand factor A domain-containing protein 3A (VWA3A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call